Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma

NCT01180049 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: temsirolimus
DRUG: temsirolimus

Sponsor

Pfizer